Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 3 | 2024 | 50 | 2.250 |
Why?
|
| Pneumonia, Bacterial | 3 | 2021 | 21 | 1.610 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2020 | 248 | 1.120 |
Why?
|
| Klebsiella Infections | 2 | 2021 | 6 | 1.000 |
Why?
|
| Klebsiella pneumoniae | 2 | 2021 | 16 | 0.990 |
Why?
|
| Lung Diseases | 1 | 2024 | 56 | 0.920 |
Why?
|
| Papillomavirus Infections | 4 | 2020 | 316 | 0.900 |
Why?
|
| Complex Mixtures | 1 | 2021 | 7 | 0.830 |
Why?
|
| Plague | 3 | 2015 | 24 | 0.780 |
Why?
|
| Yersinia pestis | 3 | 2015 | 35 | 0.770 |
Why?
|
| Calcium | 2 | 2021 | 445 | 0.700 |
Why?
|
| Cervix Uteri | 2 | 2018 | 43 | 0.700 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 15 | 0.670 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 29 | 0.660 |
Why?
|
| HIV-1 | 3 | 2015 | 678 | 0.600 |
Why?
|
| Ethanol | 1 | 2018 | 188 | 0.580 |
Why?
|
| Uterine Cervical Dysplasia | 4 | 2020 | 38 | 0.560 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 7 | 0.530 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 66 | 0.510 |
Why?
|
| Papillomaviridae | 3 | 2020 | 125 | 0.500 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2015 | 18 | 0.500 |
Why?
|
| Mice | 6 | 2024 | 5668 | 0.460 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2024 | 48 | 0.450 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 251 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 1530 | 0.420 |
Why?
|
| Interferon Type I | 1 | 2011 | 17 | 0.410 |
Why?
|
| Specimen Handling | 3 | 2020 | 49 | 0.400 |
Why?
|
| Lung | 3 | 2024 | 413 | 0.390 |
Why?
|
| Thymus Gland | 1 | 2011 | 77 | 0.390 |
Why?
|
| Cytokines | 3 | 2024 | 569 | 0.350 |
Why?
|
| Inflammation | 3 | 2024 | 577 | 0.350 |
Why?
|
| Vaginal Smears | 2 | 2020 | 52 | 0.350 |
Why?
|
| Animals | 7 | 2024 | 14307 | 0.320 |
Why?
|
| North Carolina | 4 | 2023 | 103 | 0.320 |
Why?
|
| Vagina | 2 | 2020 | 81 | 0.220 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 200 | 0.220 |
Why?
|
| Dendritic Cells | 2 | 2015 | 112 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2023 | 121 | 0.210 |
Why?
|
| Female | 8 | 2024 | 19873 | 0.210 |
Why?
|
| Feasibility Studies | 1 | 2022 | 196 | 0.200 |
Why?
|
| Chemotaxis | 1 | 2021 | 57 | 0.200 |
Why?
|
| Macrophage Activation | 1 | 2021 | 52 | 0.200 |
Why?
|
| Zebrafish | 1 | 2022 | 118 | 0.200 |
Why?
|
| Interleukin-6 | 1 | 2021 | 140 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 38 | 0.190 |
Why?
|
| DNA, Viral | 2 | 2020 | 295 | 0.190 |
Why?
|
| Humans | 13 | 2023 | 34853 | 0.190 |
Why?
|
| Human papillomavirus 16 | 1 | 2020 | 34 | 0.190 |
Why?
|
| Cytoplasm | 1 | 2020 | 135 | 0.190 |
Why?
|
| Interferon-gamma | 1 | 2021 | 235 | 0.190 |
Why?
|
| Urinalysis | 1 | 2020 | 31 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2020 | 95 | 0.180 |
Why?
|
| Patient Preference | 1 | 2020 | 46 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 325 | 0.180 |
Why?
|
| HIV Infections | 3 | 2023 | 2207 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 375 | 0.170 |
Why?
|
| Disease Progression | 2 | 2018 | 580 | 0.170 |
Why?
|
| Herpesvirus 4, Human | 1 | 2018 | 33 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 38 | 0.170 |
Why?
|
| Gene Expression | 1 | 2021 | 639 | 0.160 |
Why?
|
| Macrophages | 1 | 2021 | 431 | 0.160 |
Why?
|
| Cell Survival | 1 | 2020 | 818 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2020 | 366 | 0.150 |
Why?
|
| Early Detection of Cancer | 4 | 2020 | 292 | 0.150 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2018 | 165 | 0.150 |
Why?
|
| Aged | 4 | 2020 | 6448 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2021 | 874 | 0.140 |
Why?
|
| Middle Aged | 5 | 2020 | 9642 | 0.130 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 51 | 0.130 |
Why?
|
| Adult | 5 | 2020 | 11034 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 26 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1300 | 0.120 |
Why?
|
| Neutrophils | 1 | 2013 | 124 | 0.110 |
Why?
|
| Male | 2 | 2024 | 18870 | 0.110 |
Why?
|
| Cell Line | 2 | 2020 | 1289 | 0.110 |
Why?
|
| Flavoring Agents | 2 | 2022 | 17 | 0.110 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 13 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 99 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2010 | 25 | 0.100 |
Why?
|
| Colposcopy | 2 | 2020 | 13 | 0.090 |
Why?
|
| Virus Attachment | 1 | 2009 | 3 | 0.090 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2009 | 5 | 0.090 |
Why?
|
| Virus Internalization | 1 | 2009 | 27 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 67 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 168 | 0.090 |
Why?
|
| Interferon-alpha | 2 | 2015 | 37 | 0.060 |
Why?
|
| Sensation | 1 | 2022 | 33 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2023 | 158 | 0.050 |
Why?
|
| Perception | 1 | 2022 | 183 | 0.050 |
Why?
|
| Mentha | 1 | 2020 | 1 | 0.050 |
Why?
|
| Self-Examination | 1 | 2020 | 8 | 0.050 |
Why?
|
| Biopsy | 1 | 2020 | 151 | 0.040 |
Why?
|
| Trichomonas Vaginitis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Mycoplasma Infections | 1 | 2018 | 4 | 0.040 |
Why?
|
| Mycoplasma genitalium | 1 | 2018 | 3 | 0.040 |
Why?
|
| Trichomonas vaginalis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Postal Service | 1 | 2018 | 7 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 424 | 0.040 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2018 | 21 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 430 | 0.040 |
Why?
|
| Gonorrhea | 1 | 2018 | 31 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 2018 | 66 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 555 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 641 | 0.040 |
Why?
|
| Nicotine | 1 | 2020 | 238 | 0.040 |
Why?
|
| Self Care | 1 | 2018 | 150 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 901 | 0.040 |
Why?
|
| Chlamydia Infections | 1 | 2018 | 196 | 0.040 |
Why?
|
| Mass Screening | 1 | 2020 | 427 | 0.040 |
Why?
|
| Biological Warfare Agents | 1 | 2015 | 4 | 0.040 |
Why?
|
| Virulence | 1 | 2015 | 221 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 383 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1317 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 36 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 116 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 197 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1442 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 1802 | 0.010 |
Why?
|